Author

Eric H. Sasso

Observed names: E H Sasso, E Sasso, E. H. SASSO, E. H. Sasso, E. Sasso, E.H. Sasso, EH Sasso, ERIC H. SASSO, Eric H Sasso, Eric Sasso, Sasso, E.H., Sasso, Eric, Sasso, Eric H, Sasso, Eric H.

Institution: Myriad Genetics

Observed institutions: Uppsala University, Imperial College Healthcare NHS Trust, Lund University, University of Washington, Leiden University Medical Center, Harborview Medical Center, Abbott (United States), Reade, Reinier de Graaf Hospital, San Francisco Public Library, Maasstad Ziekenhuis, Kong Christian X's Gigthospital, Haga Hospital, Myriad Genetics, University of Birmingham, Amsterdam UMC Location Vrije Universiteit Amsterdam

ORCID: 0000-0001-6891-7980

Observed ORCID: 0000-0001-6891-7980

OpenAlex ID: A5040915422

Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

2007 · Daniel Tracey, Lars Klareskog, et al. · Pharmacology & Therapeutics · 1,626

Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor

2009 · Zehra Kaymakcalan, Paul Sakorafas, et al. · Clinical Immunology · 315

Adalimumab for long‐term treatment of psoriatic arthritis: Forty‐eight week data from the adalimumab effectiveness in psoriatic arthritis trial

2007 · Dafna D. Gladman, Philip J. Mease, et al. · Arthritis & Rheumatism · 288

Human IgA and IgG F(ab’)2 that bind to staphylococcal protein A belong to the VHIII subgroup

1991 · E H Sasso, G J Silverman, et al. · The Journal of Immunology · 212

Human IgM molecules that bind staphylococcal protein A contain VHIII H chains.

1989 · E H Sasso, G J Silverman, et al. · The Journal of Immunology · 201

Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.

2007 · Mark C Genovese, Philip J Mease, et al. · PubMed · 198

Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL

2011 · Kenneth Gordon, Kim Papp, et al. · Journal of the American Academy of Dermatology · 180

The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A.

1993 · J L Hillson, N S Karr, et al. · The Journal of Experimental Medicine · 128

Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial

2006 · D D Gladman, P J Mease, et al. · Annals of the Rheumatic Diseases · 121

Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT

2010 · Dafna D Gladman, Philip J Mease, et al. · Arthritis Research & Therapy · 106

PDF

Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial

2014 · Karen Hambardzumyan, Rebecca Bolce, et al. · Annals of the Rheumatic Diseases · 98

PDF

Less Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy Across the Spectrum of Clinical Response in Early Rheumatoid Arthritis

2009 · PAUL EMERY, MARK C. GENOVESE, et al. · The Journal of Rheumatology · 94

Antigenic specificities of human monoclonal and polyclonal IgM rheumatoid factors. The C gamma 2-C gamma 3 interface region contains the major determinants.

1988 · E H Sasso, C V Barber, et al. · The Journal of Immunology · 83

Expression of the immunoglobulin VH gene 51p1 is proportional to its germline gene copy number.

1996 · E H Sasso, T Johnson, et al. · Journal of Clinical Investigation · 72

PDF

A fetally expressed immunoglobulin VH1 gene belongs to a complex set of alleles.

1993 · E H Sasso, K Willems van Dijk, et al. · Journal of Clinical Investigation · 68

PDF

Prevalence and polymorphism of human VH3 genes.

1990 · E H Sasso, K W Van Dijk, et al. · The Journal of Immunology · 65

Long‐term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: subanalysis of REVEAL and the open‐label extension study

2012 · K. Papp, A. Menter, et al. · Journal of the European Academy of Dermatology and Venereology · 60

Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION study

2011 · J.-H. Saurat, R.G. Langley, et al. · British Journal of Dermatology · 53

Emerging human B cell repertoire. Influence of developmental stage and interindividual variation

1992 · J L Hillson, I R Oppliger, et al. · The Journal of Immunology · 53

Rheumatoid factors in immune complexes of patients with rheumatoid arthritis

1988 · Mart Mannik, Francis A. Nardella, et al. · Springer Seminars in Immunopathology · 49

A Multibiomarker Disease Activity Score for Rheumatoid Arthritis Predicts Radiographic Joint Damage in the BeSt Study

2014 · Iris M. Markusse, Linda Dirven, et al. · The Journal of Rheumatology · 46

PDF

Ethnic differences of polymorphism of an immunoglobulin VH3 gene.

1995 · E H Sasso, J H Buckner, et al. · Journal of Clinical Investigation · 46

PDF

Chromosomal organization of the human VH4 gene family. Location of individual gene segments

1993 · S van der Maarel, K W van Dijk, et al. · The Journal of Immunology · 46

Chromosomal organization of the heavy chain variable region gene segments comprising the human fetal antibody repertoire.

1992 · K Willems van Dijk, L A Milner, et al. · Proceedings of the National Academy of Sciences · 39

Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies

2021 · Jeffrey R. Curtis, Michael E. Weinblatt, et al. · Arthritis Research & Therapy · 37

PDF

Works count: 108

Citation count: 5,007

H-index: 30

I10-index: 51